Developer docs
API playgroundTry for free, no card

Search company profiles

CiNTL

Full company profile

uuid002k6kc

Namestring
CiNTL
Legal namestring
CiNTL.AI
Websiteurl
cintl-pm.com
Company typeenum
Private
Founded yearint
2024
Descriptiontext

CiNTL.AI is a Netherlands-based consultancy that operates an integrated AI, ML, and GenAI platform aimed at accelerating clinical trials for pharmaceutical and biotechnology enterprises. Founded in 2008 and headquartered in Hilversum, the company is privately held, employs 11-50 people, and presents itself as a vertical specialist addressing slow clinical trial processes, inefficient data analysis, and delayed decision-making in drug development.

The core product, branded as the CiNTL.AI Platform, combines generative AI for producing and processing clinical trial documentation, reports, and analysis with predictive analytics applied to clinical trial data for decision support. AI modalities are restricted to text. The platform is delivered through a direct online enterprise portal (with a login on the company website) targeting pharmaceutical and biotech buyers globally, though no operating geographies, named customers, or case studies are disclosed in the available material.

The business model is opaque. CiNTL.AI does not publicly disclose pricing, contract structures, revenue, funding, ownership composition, or management team details. Marketing presence is limited to organic social channels (Twitter, LinkedIn, and a Facebook-linked contact email). No certifications, regulatory clearances, partnerships, patents, or awards are disclosed, and revenue mechanics are not derivable from the inputs.

Short descriptiontext

CiNTL.AI is a Netherlands-based AI consultancy offering an integrated AI, ML, and GenAI platform that accelerates clinical trials for pharmaceutical and biotechnology enterprises from its Hilversum headquarters.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLeiden, Netherlands
HQ citystring
Leiden
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
clinical trial AI, pharmaceutical AI platform, biotech machine learning, generative AI clinical, drug development analytics
Industry3 codes
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
NAICS code2 codes
  • Custom Computer Programming Services541511
  • Software Publishers5132
SIC code2 codes
  • Services-Computer Programming Services7371
  • Services-Prepackaged Software7372
Product category
Clinical Trial AI Software
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

CiNTL.AI provides an integrated AI, ML, and GenAI platform built specifically for pharmaceutical and biotechnology companies. The platform accelerates clinical trials by applying intelligent automation, predictive analytics on trial data, and generative AI for text-based documentation, reporting, and decision support in drug development.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

CiNTL.AI offers an integrated AI, ML, and GenAI platform designed specifically for the pharmaceutical and biotech industry. The platform focuses on accelerating clinical trials through intelligent automation and data analysis capabilities.

Product and service1 record
1CiNTL.AI Platform
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Dominant cloud software provider for life sciences with its Veeva Vault Clinical suite covering trial management, eTMF, and CTMS. Represents the established enterprise incumbent that CiNTL must displace or integrate alongside in pharma accounts.

TypeBroad incumbent
Description

Industry-standard clinical trial technology platform (Rave EDC) now embedding AI/ML for protocol optimization, patient engagement, and data analytics. A scaled incumbent whose R&D and enterprise reach dwarf CiNTL's.

TypeDirect peer
Description

AI-driven clinical trial matching and patient recruitment platform serving pharma, biotech, and academic sponsors. Direct overlap with CiNTL's pharma/biotech customer base and clinical-trial acceleration use case.

TypeDirect peer
Description

Provides AI/ML-driven imaging biomarkers and analytics used to select and monitor patients in oncology clinical trials. Shares CiNTL's positioning of AI as a clinical-trial intelligence layer for pharma/biotech sponsors.

TypeEmerging player
Description

AI platform for patient identification and clinical trial pre-screening, primarily serving oncology research sites and sponsors. Comparable niche focus on accelerating trial enrollment via AI, though narrower in therapeutic scope than CiNTL.

6Mendel
TypeDirect peer
Description

AI platform purpose-built for life sciences that structures clinical and biomedical text to support trial design, patient cohort identification, and regulatory workflows. Closely aligned with CiNTL's text-modality GenAI use cases for clinical trial documentation and analysis.

7Unlearn.AI
TypeDirect peer
Description

Applies generative AI to create digital twin patients that improve clinical trial statistical power and accelerate timelines for pharma sponsors. Shares CiNTL's positioning of AI/GenAI as a direct lever on clinical trial speed and intelligence.

TypeBroad incumbent
Description

Largest global CRO and life sciences technology vendor, embedding AI across clinical trial design, site identification, and real-world evidence. A broad incumbent competing for the same pharma AI-for-clinical-trials budget as CiNTL.

9Deep 6 AI
TypeDirect peer
Description

AI platform that mines structured and unstructured clinical data to accelerate patient recruitment and trial feasibility for pharma sponsors. Directly comparable to CiNTL.AI's clinical trial acceleration focus, serving the same pharma/biotech buyer with AI-driven trial intelligence.

TypeDirect peer
Description

Decentralized clinical trial operating system that uses AI to enable remote patient participation and faster enrollment for pharma sponsors. Overlaps CiNTL's value proposition of accelerating clinical trials through technology-enabled intelligence.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CiNTL

Clinical Trial AI Softwarecintl-pm.com

CiNTL.AI is a Netherlands-based AI consultancy offering an integrated AI, ML, and GenAI platform that accelerates clinical trials for pharmaceutical and biotechnology enterprises from its Hilversum headquarters.

What CiNTL does

CiNTL.AI is a Netherlands-based consultancy that operates an integrated AI, ML, and GenAI platform aimed at accelerating clinical trials for pharmaceutical and biotechnology enterprises. Founded in 2008 and headquartered in Hilversum, the company is privately held, employs 11-50 people, and presents itself as a vertical specialist addressing slow clinical trial processes, inefficient data analysis, and delayed decision-making in drug development.

The core product, branded as the CiNTL.AI Platform, combines generative AI for producing and processing clinical trial documentation, reports, and analysis with predictive analytics applied to clinical trial data for decision support. AI modalities are restricted to text. The platform is delivered through a direct online enterprise portal (with a login on the company website) targeting pharmaceutical and biotech buyers globally, though no operating geographies, named customers, or case studies are disclosed in the available material.

The business model is opaque. CiNTL.AI does not publicly disclose pricing, contract structures, revenue, funding, ownership composition, or management team details. Marketing presence is limited to organic social channels (Twitter, LinkedIn, and a Facebook-linked contact email). No certifications, regulatory clearances, partnerships, patents, or awards are disclosed, and revenue mechanics are not derivable from the inputs.

CiNTL firmographics

Firmographics
Name
CiNTL
Legal name
CiNTL.AI
Website
https://cintl-pm.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
CiNTL.AI is a Netherlands-based AI consultancy offering an integrated AI, ML, and GenAI platform that accelerates clinical trials for pharmaceutical and biotechnology enterprises from its Hilversum headquarters.
Ownership category
akta.pro rank

CiNTL industry classification

Industry
Product category
Clinical Trial AI Software
NAICS
Custom Computer Programming Services (541511), Software Publishers (5132)
SIC
Services-Computer Programming Services (7371), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise

Keywords

  • Clinical trial AI
  • Pharmaceutical AI platform
  • Biotech machine learning
  • Generative AI clinical
  • Drug development analytics

Where CiNTL is headquartered

Location

Headquarters

HQ city
Leiden
HQ country
Netherlands
HQ region
Europe

Markets served

CiNTL business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels3 records

CiNTL product offering

Product offering

Core offering

CiNTL.AI provides an integrated AI, ML, and GenAI platform built specifically for pharmaceutical and biotechnology companies. The platform accelerates clinical trials by applying intelligent automation, predictive analytics on trial data, and generative AI for text-based documentation, reporting, and decision support in drug development.

Product overview

CiNTL.AI offers an integrated AI, ML, and GenAI platform designed specifically for the pharmaceutical and biotech industry. The platform focuses on accelerating clinical trials through intelligent automation and data analysis capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • CiNTL.AI Platform

Companies that use CiNTL

Customer profile

Segments2 records

Ideal customer profiles2 records

CiNTL technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature1 record

CiNTL partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights2 records

CiNTL competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Dominant cloud software provider for life sciences with its Veeva Vault Clinical suite covering trial management, eTMF, and CTMS. Represents the established enterprise incumbent that CiNTL must displace or integrate alongside in pharma accounts.
  • Medidata (Dassault Systèmes): Industry-standard clinical trial technology platform (Rave EDC) now embedding AI/ML for protocol optimization, patient engagement, and data analytics. A scaled incumbent whose R&D and enterprise reach dwarf CiNTL's.
  • IQVIA: Largest global CRO and life sciences technology vendor, embedding AI across clinical trial design, site identification, and real-world evidence. A broad incumbent competing for the same pharma AI-for-clinical-trials budget as CiNTL.

Direct peers

  • TrialX: AI-driven clinical trial matching and patient recruitment platform serving pharma, biotech, and academic sponsors. Direct overlap with CiNTL's pharma/biotech customer base and clinical-trial acceleration use case.
  • Median Technologies: Provides AI/ML-driven imaging biomarkers and analytics used to select and monitor patients in oncology clinical trials. Shares CiNTL's positioning of AI as a clinical-trial intelligence layer for pharma/biotech sponsors.
  • Mendel: AI platform purpose-built for life sciences that structures clinical and biomedical text to support trial design, patient cohort identification, and regulatory workflows. Closely aligned with CiNTL's text-modality GenAI use cases for clinical trial documentation and analysis.
  • Unlearn.AI: Applies generative AI to create digital twin patients that improve clinical trial statistical power and accelerate timelines for pharma sponsors. Shares CiNTL's positioning of AI/GenAI as a direct lever on clinical trial speed and intelligence.
  • Deep 6 AI: AI platform that mines structured and unstructured clinical data to accelerate patient recruitment and trial feasibility for pharma sponsors. Directly comparable to CiNTL.AI's clinical trial acceleration focus, serving the same pharma/biotech buyer with AI-driven trial intelligence.
  • Science 37: Decentralized clinical trial operating system that uses AI to enable remote patient participation and faster enrollment for pharma sponsors. Overlaps CiNTL's value proposition of accelerating clinical trials through technology-enabled intelligence.

Emerging players

  • Deep Lens: AI platform for patient identification and clinical trial pre-screening, primarily serving oncology research sites and sponsors. Comparable niche focus on accelerating trial enrollment via AI, though narrower in therapeutic scope than CiNTL.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

CiNTL social profiles

Digital presence

CiNTL financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CiNTL leadership team

Management profile

Number of profiles

CiNTL funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CiNTL M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CiNTL

What does CiNTL do?

CiNTL.AI provides an integrated AI, ML, and GenAI platform built specifically for pharmaceutical and biotechnology companies. The platform accelerates clinical trials by applying intelligent automation, predictive analytics on trial data, and generative AI for text-based documentation, reporting, and decision support in drug development.

Is CiNTL a public or private company?

CiNTL is a private company. It is classified as unknown and is currently operating.

When was CiNTL founded?

CiNTL was founded in 2024. It employs 11 to 50 people.

Where is CiNTL based?

CiNTL is headquartered in Leiden, Netherlands, in the Europe region.

Who are CiNTL's main competitors?

Broad incumbents on record are Veeva Systems, Medidata (Dassault Systèmes) and IQVIA. Direct peers are TrialX, Median Technologies, Mendel, Unlearn.AI, Deep 6 AI and Science 37. Deep Lens is listed as an emerging player.

Does CiNTL have an API?

No public API is recorded for CiNTL.

What industry is CiNTL in?

CiNTL's product category is Clinical Trial AI Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HDAEANAA, End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management). Its NAICS code is 541511 and its SIC code is 7371.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales